Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRL790 in PD with Levodopa-Induced Dyskinesia
NCT03531060Phase 2Completed
- Sponsor
- IRLAB
- Start
- Nov 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of mesdopetam in levodopa-induced dyskinesia (LID), sponsored by IRLAB. Started Nov 2016; status: completed.
02
Drugs
mesdopetam
03
Conditions
levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on NCT03531060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03531060.